Inivata is a Leader

in Liquid Biopsy
Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients

Our US Medicare-reimbursed lead product InVisionFirst-Lung is already transforming the lives of advanced NSCLC patients

Our Mission

We are transforming the lives of cancer patients and their families through the power of liquid biopsy

Our Technology

Contact Us

Latest News and Events

Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study

Inivata to provide ctDNA liquid biopsy using its InVisionFirst®-Lung test to analyze resistance in patients treated with lorlatinib ... Read More

Clinical utility of ctDNA genomic alterations (GA) based on ESMO scale for clinical actionability of molecular targets (ESCAT) in advanced NSCLC

L. Mezquita, D. Planchard, M. Dorta, M. Aldea, C. Naltet, V. Lamberts, M. Grecea, P. Martin-Romano, F. de Kievit, C. Jovelet, E. ... Read More

Advances in Liquid Biopsies Conference

Advances in Liquid Biopsies Conference

Event expiration date display - 13 - 16 JAN 2020

Location: California Read More

Changing Lives

Patients are at the heart of everything we do.

Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives. 

This is the story of the first patient Inivata tested.

Transforming the lives of Cancer Patients and Their Families

As a dynamic and innovative company, we focus on the development of ground-breaking technology in a fast-paced and international setting.

Our team of talented and driven individuals work together to combine their energy and expertise in world-class research, product development and commercialization. Join us.

Inivata CEO Clive Morris speaks on protecting the UK #Lifesciences amidst election uncertainty - here in this @Telegraph special report:

Since our foundation, CIC has attracted £1 billion of investment into #Cambridge companies. Today we’re delighted to provide an update on our strong performance over the past 6 months: #Innovation #tech #lifesciences

We'd like to wish everyone celebrating a very #HappyThanksgiving from all of us at #TeamInivata